Your Cart is Empty
If you notice a decline in your sense of smell, there may be reason for concern. Olfactory function naturally decreases with age, and its loss can also be an early indicator of neurodegenerative disorders. New research links a declining sense of smell to a faster accumulation of Alzheimer’s-related brain changes observed in brain scans.
A reduced ability to smell may signal upcoming memory issues and a higher risk of Alzheimer’s disease. The research strengthens the evidence that loss of smell is an early indicator of Alzheimer’s-related cognitive decline and the buildup of harmful proteins, such as amyloid and tau in the brain.
The study included 364 participants from the Baltimore Longitudinal Study of Aging, all cognitively normal at the beginning of the testing. For the next 2.5 years, they underwent baseline cognitive tests, odor identification assessments, and brain imaging scans.
To investigate the link between olfactory function and brain volume, researchers compared odor identification scores with brain MRI scans. Participants who developed cognitive impairment or dementia exhibited lower odor identification scores compared to those who remained cognitively normal.
The study results found that 5% of the monitored participants were diagnosed with mild memory impairment, a stage characterized by declining cognition that may progress to Alzheimer’s disease.
The brain scans showed that participants with a declining sense of smell exhibited brain changes characteristic of Alzheimer’s disease. As their olfactory function decreased, the presence of plaques and tangles increased in brain regions essential for learning and smell processing.
The study reveals a significant link between reduced smell sensitivity and an increased risk of developing mild cognitive impairment and other dementia types. Researchers plan to further investigate whether olfactory decline can predict other neurodegenerative changes associated with dementia.
To view the original scientific study click below:
Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults
Everywhere in our surroundings, minuscule plastic fragments invade the human body daily through foods and liquids we consume, and airborne particles we inhale. These pervasive invaders spread throughout every organ and tissue, reaching even the brain, where buildup may spark symptoms resembling Alzheimer's disease. A new study revealed concerning levels of microplastic buildup in the human brain.
Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.
A recent study suggests that consuming high-fat foods for just a few days can trigger issues, including cognitive decline. Availability of brain glucose is rapidly and reversibly reduced, activating inhibitory neurons and disrupting memory formation. The results highlight the significant role of nutrition in contributing to cognitive decline and the development of Alzheimer’s disease.